“Marc Cohodes joins me talk to about OSTK stock recently getting plowed after a potential $1.5B valuation was supposedly placed on it by GSR Capital, according to the company’s recent press release. I ask Marc about some of the rumors about GSR, concerns raised by some of his critics on Twitter, the company’s recent shelf offering, MiMedx and people who think he acts like a bully online,” writes the raven.